Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the first…
Super UserMay 4, 2020
The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing…
Super UserMay 4, 2020
Gilead Sciences’ closely-watched COVID-19 drug candidate remdesivir outperformed placebo in a clinical trial sponsored by the NIH’s National Institute of…
Super UserMay 4, 2020
Gilson and QIAGEN have entered into a strategic partnership that will provide researchers the ability to limit operator-dependent variation in…
Super UserMay 4, 2020
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic | TechCrunch
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings,…
Super UserMay 4, 2020
BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, announced today that the company has received market clearance…
Super UserApril 28, 2020
BALTIMORE, Md., April 27, 2020 /PRNewswire/ -- LifeSprout, a privately-held regenerative medicine company founded with technology licensed from Johns Hopkins University,…
Super UserApril 28, 2020
Gentian AS, a Norwegian company, with its US office at BioHealth Innovation in Rockville, Maryland is seeking collaborators to investigate…
Super UserApril 27, 2020
Alexandria LaunchLabs™ in Maryland, will provide fully equipped, affordable laboratory/office space with flexible lease terms, supporting infrastructure, access to amenities,…
Super UserApril 27, 2020